
DCI Blog
Berchuck-Named Gynecologic Oncology Endowed Lectureship Launches
Features Andrew Berchuck, MD
LeBlanc Honored for Advocacy, Named Education Chair for ASCO24
Features Thomas LeBlanc, MD, MA, MHS, FAAHPM, FASCO
Akinyemiju, Garman, and Zani Receive Faculty Awards
Features Tomi Akinyemiju, PhD; Katherine Garman, MD, MHS; Sabino Zani Jr., MD
Ten DCI Faculty Awarded Distinguished Professorships
Features Peter Allen, MD, PhD; Michel Bagnat, PhD; Daniel George, MD; Gerald Grant, MD; Matthias Gromeier, MD; Susan Halabi, PhD; Seok-Yong Lee, PhD; Steven Patierno, PhD; John Rawls, PhD; Beth Sullivan, PhD
Three DCI Nurses Win FON Excellence Awards
Features Deborah “Hutch” Allen, PhD, RN, CNS, FNP-BC, AOCNP; Nicole “Nicki” Murray Coates, BSN, RN, OCN; and Meagan Salmon, BSN, RN, OCN
Annual Men's Health Screening Draws a Crowd
Features Angelo Moore, PhD, RN, NE-BC, and Kearston Ingraham, MHA
AI-Driven Biomarker Predicts Optimum Length of Treatment for Prostate Cancer
Features Andrew Armstrong, MD, MSc
Black Men with Metastatic Prostate Cancer May Benefit From Drug Combination
Features Daniel George, MD
Plus: Dan George ASCO Twitter video explaining his research
Oncologist & Patient Talk About Their 16-Year Multiple Myeloma Journey in Video Podcast
Features Cristina Gasparetto, MD, and her patient Thomas Goode
Allen Named DUHS Vice President for Cancer Services
Features Peter Allen, MD, PhD
Cancer Takes its Toll on St. Pauls Woman, but Can’t Steal Her Joy for Life
Features Hannah McManus, MD
ICYMI at DUKE
Creating Community for Asian American Students (Duke School of Medicine)
Features Duke Cancer Center
Lafata Recognized with Professorship Named for Duke RadOnc Legend (Duke RadOnc)
Features Kyle J. Lafata, PhD
Medical Students Select 2023 Golden Apple Award (Duke School of Medicine)
Features Kristen Rhodin, MD
ICYMI at DUKE, cont.
New Focus on Improving Melanoma Therapies for Older Patients (Clinical Practice Today)
Features Jay Lee, MD, in Wake County
Head and Neck Cancer Awareness month screening at Mudcats game (Department of Head & Neck Surgery and Communication Sciences
Features Trinitia Cannon, MD
This is Something We Haven't Seen in 20 Years" New Brain Tumor Treatment May Extend Life and Slow Difficult Treatment Options (Duke Neurology)
Features Katy Peters, MD, PhD
Alexandra Bennion Receives Biology Faculty Award (Duke Pathology)
More Options for People with Blood Cancers (Duke SoM Magnify)
Features Mitchell Horwitz, MD
Forward Together: Building a Culture of Encouragement: By supporting a colleague’s growth, Duke Blood Cancer Center creates a spirit of togetherness (Duke Today)
Features Mary Beth Christen, BSN, RN, BMTCN
Michelle Winn Awards Celebrate Achievements in Diversity and Inclusion (Duke School of Medicine)
Features Tomi Akinyemiju, PhD
Duke Scientists Uncover Ferroptosis as a Potential “Achilles Heel” in RB1-Deficient Prostate Cancer (Duke Pathology)
Featuring Ming Chen, PhD, and fellow Mu-En Wang, PhD, Jiaoti Huang, MD, PhD, and Andrew Armstrong, MD, MSc
Individualized Care, Experienced Specialists Lead GI Cancer Team in Wake (Clinical Practice Today)
Features Garth Herbert, MD
House Cancer Caucus Briefing on Chemotherapy Shortages (Duke Ob/Gyn Blog)
Features Angeles Alvarez Secord, MD, MHSc
Kidney Donor Evaluation Leads to Stomach Cancer Discovery (Duke Health)
Features Hope Uronis, MD
Lung Cancer Screening Team Focuses on Reducing Mortality (Clinical Practice Today)
Features Betty Tong, MD
Duke U Commencement (Duke University)
WATCH: MD graduates’ Commencement (Duke SoM)
Study Reveals How UV Radiation May Drive Melanoma (Duke School of Medicine)
Features Raluca Gordân, PhD
MEDIA
$5M project brings optimized radiation treatment to Wilson (The Wilson Times)
Features Linda Sutton, MD
Destination Midtown: Duke Raleigh Hospital’s Art Suite (CBS 17)
World-class cancer treatment is now close to home (Murray Ledger & Times)
Features Alexander Diaz, MD, PhD
Encourage men to get screened, health experts say (Butner-Creedmoor News)
Features Duke Cancer Institute
Triangle Cancer patients worry about Chemo shortages (CBS 17)
Features Angeles Alvarez Secord, MD, MHSc
Amidst Advancements in Treating Cancer, Oncologists Face New Challenge: Drug Shortages (ABC-11)
Features Angeles Alvarez Secord, MD, MHSc, and Kristy Sartin
As cancer drug shortages grow, some doctors are forced to ration doses or delay care (NBC News)
Features Angeles Alvarez Secord, MD, MHSc
US cancer drug shortage forces doctors to ration life-saving treatments (The Financial Times)
Features Angeles Alvarez Secord, MD, MHSc
North Carolina cancer patients worry about Chemo drug shortages (WGHP Greensboro)
Features Angeles Alvarez Secord, MD, MHSc
Duke Cancer Center Hosts Annual Survivorship Day (CBS-17)
Features Kristy Sartin and patient Connie High
'It's very important': Duke Cancer Center in Durham offers free health screenings (ABC-11)
Features Angelo Moore, PhD, RN, and patient Bradley Long
NC breast cancer survivor reveals the moment her world changed at 28 (WRAL)
Features Maggie DiNome, MD
'Rocked my world.' Breast cancer survivor reacts to new screening recommendations (ABC-11)
Features Maggie DiNome, MD
'Always about hope': Ukrainian artist with cancer paints new life in North Carolina (ABC-11)
Features Duke Cancer
Pushing a More Complete Picture (Triangle Business Journal)
Features Karen Johnson, MD, MS
Trades
The current incidence, evaluation, and management of male breast cancer (SurgOnc Today)
Features Jennifer Plichta, MD, MS
Potential targets against natural killer/T-cell lymphoma found (Labiotech (Eu))
Features Ong Choon Kiat, PhD (Duke NUS)
Study reveals racial inequities in lung cancer screening among veterans (HCP Live)
Features Neelima Navuluri, MD, MPH
Black patients face 34% lower odds of completing lung cancer screening after a referral, (Radiology Business)
Features Neelima Navuluri, MD, MPH
Fewer black veterans complete referrals for lung cancer screening (HealthDay)
Features Neelima Navuluri, MD, MPH
Better With Aging: Improving breast cancer care in older adults (Medscape Video Series)
Features Rebecca Shelby, PhD
Episode 1: The Difference Age Makes
Features Gretchen Kimmick, MD, Rebecca Shelby, PhD, Lisa Massa, MPT
Dr Armstrong on the FDA Approval of Abiraterone/Olaparib Combination in BRCA-mutated mCRPC (OncLive)
Features Andrew Armstrong, MD, MSc
FDA approval insights: Olaparib plus Abiraterone in BRCA-mutated mCRPC (Onc Live) Features Andrew Armstrong, MD, MSc
ODAC decision for Olaparib/ Abiraterone in mCRPC likely to impact forthcoming studies (Targeted Oncology)
Features Andrew Armstrong, MD, MSc
FDA Approves Olaparib Triplet for mCRPC (Targeted Oncology)
Features Andrew Armstrong, MD, MSc
Approval of Olaparib Combo Impacts SOC in BRCA-Mutant Metastatic CRPC (Cancer Network)
Features Andrew Armstrong, MD, MSc
FDA Approves Olaparib Combo in BRCA-Mutated mCRPC (Cancer Network)
Features Andrew Armstrong, MD, MSc
FDA Approves Olaparib Combination to Treat BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer (AJMC)
Features Andrew Armstrong, MD, MSc
FDA OKs Olaparib-Abiraterone for Metastatic Prostate Cancer (Medpage Today)
Features Andrew Armstrong, MD, MSc
Olaparib Gains BRCA-Mutated Prostate Cancer Indication (Medscape)
Features Andrew Armstrong, MD, MSc
The Evolution of Treatment Paradigms in Metastatic Castration-Resistant Prostate Cancer (mCRPC) (OncLive)
Features Andrew Armstrong, MD, MSc
VIDEO: ASCO® 2023 Insights: "BC Staging for Patients With 'Low-Risk' Disease - Are They All the Same?" (ASCO)
Features Jennifer Plichta, MD, MS
Gastrointestinal Stromal Tumors That Lack KIT and PDGFRA Mutations (Expert Perspectives in Oncology)
Features Richard Riedel, MD
It's Okay to Say 'No': Setting Boundaries in Oncology (Medscape)
Features Arif Kamal, MD, MBA, MHS
Cancer drug shortages spur worry, rationing and tough choices (MD Edge)
Features Arif Kamal, MD, MBA, MHS
Patients with poor-prognosis metastatic NSCLC benefit from Nivolumab and Ipilimumab (Targeted Oncology)
Features Neal Ready, MD, PhD
ASC officer provides ASCO highlights: Targeting hidden cancer, AI in oncology (MD Edge) Features Arif Kamal, MD, MBA, MHS
Making the Art of Oncology and Cancer Care Central to Her Presidential Term: A Conversation With Lynn M. Schuchter, MD, FASCO (The ASCO Post)
Features Thomas LeBlanc, MD, MA, MHS, FAAHPM, FASCO
Investigators of the phase 1/2 KOMET-001 trial are seeking to address unmet needs in AML with the investigational menin inhibitor ziftomenib (OncLive)
Features Harry Erba, MD, PhD
Ziftomenib displays early-phase efficacy in relapsed or refractory AML (Onc Live)
Features Harry Erba, MD, PhD
Taking cardiotoxicity to heart in cancer patients (Pharmacy Practice News)
Features Kristen Peterson, PharmD
Cardiac event management is a key aspect of safely treating patients with Ribociclib in advanced breast cancer (Oncology Nursing News)
Features Rita Deimler, NP
FDA panel rejects broad Olaparib indication in metastatic CRPC (Medpage Today)
Features Daniel George, MD
Onco-nursing experts define best practices, treatment considerations for managing patients with MPNs (Oncology Nursing News)
Features Jill Brennan-Cook, DNP, RN, BC-GERO
Study identifies disparities in prostate cancer screening for transgender women (Urology Times)
Features Hayley Premo, MS (3rd year med student)
That lump on your testicle doesn’t automatically scream cancer (Get Me Giddy)
Features Aaron Lentz, MD
Episode 257: Redefining the Bell: The Ethics of Hope for Oncology Nurses and Patients (Oncology Nursing Society)
Features Monica Cfarku, RN, MSN, BMTCN, CCM, NE-BC
Addition of Quizartinib to chemotherapy in newly diagnosed FLT3-ITD-positive acute myeloid leukemia (The ASCO Post)
Features Harry Erba, MD, PhD
Quizartinib Plus Chemotherapy Emerges as Potential Option for FLT3-ITD-Mutant AML (Targeted Oncology)
Features Harry Erba, MD, PhD
FLT3 Inhibitor Doubles Overall Survival in Acute Myeloid Leukemia (Medpage Today)
Features Harry Erba, MD, PhD
Exploring racial biases in clinical trials: The PANTHER study’s findings on prostate cancer, (Uro Today)
Features Daniel George, MD
Emotional Impacts of Side Effects on Patients and Caregivers (Checkpoint Now Podcast Series)
Featuring Afreen Shariff, MD; Tian Zhang, MD; and Rebecca Shelby, PhD
Olatec Therapeutics Announces the Completion of First Dose Cohort in an Innovative Trial Investigating Olatec’s NLRP3 Inhibitor Dapansutrile and Merck’s Keytruda® in Patients with Advanced Refractory Melanoma at Duke Cancer Institute (Olatec Therapeutics press release)
Features April Salama, MD
(BOOK) Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice
Features co-author Alice Maupin, MSN, RN
ER-Positive/ HER2-Negative Breast Cancer condition guide (The Mighty)
Features Rani Bansal, MD
The many aspects of early detection and interception of cancer (AACR Blog)
Features Shelley Hwang, MD, MHS
Vorasidenib alone improved progression-free survival in patients with residual or recurrent IDH-mutant low-grade glioma, meeting the primary end point of the phase 3 INDIGO trial (Targeted Oncology)
Features Katy Peters, MD, PhD
Opening Plenary Session showcases important breakthroughs across the spectrum of cancer research (AACR)
Features Tomi Akinyemiju, PhD
Creating a ‘parts list’ for cancer’s spread, with help from a worm (Oncology News)
Features David Sherwood, PhD
Adjuvant Endocrine Therapy for Localized Breast Cancer – Key Facts for Primary Care Providers (CME-certified (0.5 credit) tweetorial)
Features Rani Bansal, MD
Response to Bipolar Androgen Therapy and PD-1 Inhibition in a Patient with Metastatic Castration-Resistant Prostate Cancer and a Germline CHEK2 Mutation - Beyond the Abstract (UroToday)
Features Andrew Armstrong, MD, MSc
Papers
Dendritic cell vaccine trials in gliomas: Untangling the lines Neuro-Oncology June 8, 2023 Kelly M Hotchkiss, Kristen A Batich, Aditya Mohan, Rifaquat Rahman, Steven Piantadosi, Mustafa Khasraw
Trends and Disparities in Clinical Trial Enrollment as Part of First-Line Treatment for Upper Gastrointestinal and Hepatopancreatobiliary Malignancies (Annals of Surgical Oncology) Kristen Rhodin MD; Vignesh Raman MD, MHS, Elishama Kanu MD, Austin Eckhoff MD, Daniel P. Nussbaum MD, Michael E. Lidsky MD & Dan G. Blazer III MD
Establishing massively parallel models to examine the influence of cell heterogeneity on tumor growth
Journal of Computational Science May 28, 2023 Cyrus Tanade, Sarah Putney, Amanda Randles
Characterization of industry relationships in oncology Cancer May 25, 2023 Rebecca A. Harrison MD, Nazanin K. Majd MD, PhD, Margaret O. Johnson MD, Diana L. Urbauer MS, Vinay Puduvalli MD, Mustafa Khasraw MD
External Validation of a Prognostic Model of Overall Survival in Men With Chemotherapy-Naıve Metastatic Castration-Resistant Prostate Cancer ASCO JCO Susan Halabi, PhD; Qian Yang, PhD; Akash Roy, PhD; Bin Luo, PhD; John C. Araujo, MD; Christopher Logothetis, MD; Cora N. Sternberg, MD; Andrew J. Armstrong, MD; Michael A. Carducci, MD; Kim N. Chi , MD; Johann S. de Bono, MD; Daniel P. Petrylak , MD; Karim Fizazi, MD; Celestia S. Higano, MD; Michael J. Morris, MD; Dana E. Rathkopf, MD; Fred Saad , MD; Charles J. Ryan, MD; Eric J. Small, MD; and William Kevin Kelly, DO
RELATED VIDEO: Susan Halabi, PhD, explains her recent JCO ASCO study (Twitter)
PSMA-positive Circulating Tumor Cell Detection and Outcomes with Abiraterone or Enzalutamide Treatment in Men with Metastatic Castrate-resistant Prostate Cancer Clin Cancer Res 29, no. 10 May 15, 2023 Santosh Gupta, Susan Halabi, Qian Yang, Akash Roy, Alisa Tubbs, Yamini Gore, Daniel J. George, David M. Nanus, Emmanuel S. Antonarakis, Daniel C. Danila, Russell Z. Szmulewitz, Richard Wenstrup, Andrew J. Armstrong
Development and validation of a unifying pre-treatment decision tool for intracranial and extracranial metastasis-directed radiotherapy. (Front Oncol) March 27, 2023. Trey C Mullikin, William Breen, Hunter C Gits.
Durable responses in patients with HER2+ breast cancer and leptomeningeal metastases treated with trastuzumab deruxtecan. (NPJ Breast Cancer) March 30, 2023. Laura Alder, Claire Bradbury, Amanda E D Van Swearingen, Mustafa Khasraw, Cary Anders
Newsmakers
DCI E-NEWS ARCHIVES
DCI E-NEWS June 9, 2023 Chemo Shortage :: ASCO :: Men’s Health :: Mom of the Year :: Melanoma Drivers :: Survivors
DCI E-NEWS May 2, 2023 Survivor Moms :: Cord Blood :: Fetal GBM :: Surgeon of the Year :: Rossi & Robotics
DCI E-NEWS April 4, 2023 Secord New President :: Allen Inroads :: New Wake Oncologists :: Covid & Cancer
DCI E-NEWS March 14, 2023
5 Faculty Leaders :: Camouflage :: Grey's Anatomy :: CRC Warning :: RCC Disparities
DCI E-NEWS February 17, 2023
Drug Discoveries :: Irish Brogue :: Breast Map :: New OBGyn Mag :: Cancer History Project